蛋白质印迹市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

蛋白质印迹市场按产品(仪器、耗材)、应用、最终用户和地理位置细分

市场快照

Picture2_Neuroendocrine Tumor Treatment Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

蛋白质印迹市场的主要驱动因素包括全球慢性病负担的增加、生物技术和制药行业不断增长的研究活动以及制药和生物技术公司的研发投资增加。

蛋白质印迹是一种广为人知和使用的测试,用于细胞和分子生物学。借助这项测试,人们可以从从细胞中提取的复杂蛋白质混合物中检测出特定类型的蛋白质。由于其特异性、低成本和易用性,该测试在市场上获得了吸引力。 

尽管这项技术自问世以来就不断发展,但在过去十年中,这项技术取得了一些进步。毛细管和微流体平台的引入是其中一项进步,它极大地帮助减少了测试时间,降低了样品需求,同时实现了高通量能力。因此,由于蛋白质印迹测试的某些特征,市场被认为在预测期内将出现相当大的增长。

报告范围

根据报告的范围,蛋白质印迹是一种分析技术,用于分子生物学、免疫遗传学和其他诊断学科,用于从组织匀浆或提取物样本中鉴定特定蛋白质。

By Product
Instruments
Gel Electrophoresis Instruments
Blotting Systems
Imagers
Chemiluminescent Imagers
Fluorescent Imagers
Others
Consumables
Reagents
Kits
By Application
Biomedical & Biochemical Research
Disease Diagnostics
Others
By End-User
Academia and Research Institutes
Diagnostic Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

疾病诊断部门将在预测期内见证健康的复合年增长率

蛋白质印迹检测在医学诊断中有着广泛的应用。用于诊断 BSE(牛海绵状脑病)、FIV(猫免疫缺陷病毒)、HBV(乙型肝炎病毒)感染、莱姆病等疾病。

一般在ELISA检测结果为阳性后,该检测作为上述疾病的确认检测。对于莱姆病,美国 FDA 建议首先使用 ELISA 测试的两层方案,然后如果 ELISA 的结果为阳性,则使用特定的蛋白质印迹测试来确认诊断。 

以前,通常进行蛋白质印迹以确认 HIV 诊断。然而,今年疾病控制和预防中心 (CDC) 已建议停止对 HIV 进行蛋白质印迹检测,因为市场上出现了用于 HIV 检测的新技术。此外,研究表明蛋白质印迹是诊断 BSE(牛海绵状脑病)和 FIV(猫免疫缺陷病毒)等疾病的优先测试。因此,由于该测试在疾病诊断中的重要性,表明该部分将在预测期内见证健康的复合年增长率。

Picture3_Neuroendocrine Tumor Treatment Market

北美有望主导蛋白质印迹市场

全球蛋白质印迹市场由北美地区主导,美国占据该市场的最大份额。促成美国大份额的主要因素是发达的医疗保健系统和该国主要参与者的存在。 

Bio-Rad、Thermo Fisher Scientific 等公司在美国市场活跃,由于美国人口对新产品或技术的适应性,公司能够在美国推出新产品这正在帮助研究的市场在该地区发展。 

Western Blotting Market - Growth Rate by Region - Image

竞争格局

主要参与者之间正在争夺市场份额,随着该测试应用的不断增加以及制药和生物技术行业的发展,相信很少有中小型公司会很快进入市场并在市场上占有相当大的份额。市场。在蛋白质印迹市场上运营的主要市场参与者包括 Danaher Corporation、Thermofisher Scientific、Biorad Laboratory、Perklin Elmer 和 Merck KgaA 等

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Proteomics Market Across the Globe

      2. 4.2.2 Increasing R&D Investment by the Pharma and Biotech Companies

      3. 4.2.3 Wide Applications of the Western Blot Test

    3. 4.3 Market Restraints

      1. 4.3.1 Availability of the Alternatives for Western Blot

      2. 4.3.2 Accuracy Issues

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Instruments

        1. 5.1.1.1 Gel Electrophoresis Instruments

        2. 5.1.1.2 Blotting Systems

        3. 5.1.1.3 Imagers

          1. 5.1.1.3.1 Chemiluminescent Imagers

          2. 5.1.1.3.2 Fluorescent Imagers

          3. 5.1.1.3.3 Others

      2. 5.1.2 Consumables

        1. 5.1.2.1 Reagents

        2. 5.1.2.2 Kits

    2. 5.2 By Application

      1. 5.2.1 Biomedical & Biochemical Research

      2. 5.2.2 Disease Diagnostics

      3. 5.2.3 Others

    3. 5.3 By End-User

      1. 5.3.1 Academia and Research Institutes

      2. 5.3.2 Diagnostic Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bio-Rad Laboratories, Inc.

      2. 6.1.2 Thermo Fisher Scientific, Inc.

      3. 6.1.3 LI-COR Biosciences

      4. 6.1.4 Bio-Techne Corporation

      5. 6.1.5 Merck KGaA

      6. 6.1.6 PerkinElmer, Inc.

      7. 6.1.7 Cell Signaling Technology

      8. 6.1.8 Advansta, Inc.

      9. 6.1.9 Danaher Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Western Blotting Market market is studied from 2018 - 2026.

The Western Blotting Market is growing at a CAGR of 6.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, PerkinElmer, Inc., Danaher Corporation are the major companies operating in Western Blotting Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!